GETI-B:STO
Getinge AB
SEKÂ 248,60
arrow_upward
+0,57%(+1,40) 1D
2 okt, 10:49:45 GMT+2 · SEK
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor GETI-B genereren…
Openen
SEKÂ 247,20
Hoog
SEKÂ 248,80
Laag
SEKÂ 245,90
Beursw.
63,18Â mld.
Gem. vol.
578,42K
Volume
19,90K
Dividend
1,91%
Kwartaaldividend
SEKÂ 1,19
Ex-dividenddatum
22 apr 2026
Koers/winst-verhouding
25,32
52 wk hoog
SEKÂ 251,40
52 wk laag
SEKÂ 175,90
WPA
SEKÂ 9,82
Uitstaande aandelen
254,15Â mln.
Aantal medewerkers
12K
Openen
SEKÂ 247,20
Hoog
SEKÂ 248,80
Laag
SEKÂ 245,90
Beursw.
63,18Â mld.
Gem. vol.
578,42K
Volume
19,90K
Dividend
1,91%
Kwartaaldividend
SEKÂ 1,19
Ex-dividenddatum
22 apr 2026
Koers/winst-verhouding
25,32
52 wk hoog
SEKÂ 251,40
52 wk laag
SEKÂ 175,90
WPA
SEKÂ 9,82
Uitstaande aandelen
254,15Â mln.
Aantal medewerkers
12K
Nieuwsartikelen
Van webbronnen en nieuwspartners
AD HOC NEWS
·
1 dag geleden
Getinge B stock ahead of the Xetra open: prior close EUR 21.81 on September 30, 2026
Profiel
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
Over Getinge AB